Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...
News-Medical.Net on MSN
JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth
On January 14, Dr. Chris Chen, CEO of WuXi Biologics, delivered a keynote at the 44th J.P. Morgan Healthcare Conference, ...
NextCell Pharma AB ("NextCell" or the "Company") provides a strategic update on its focused market progression strategy, aimed at accelerating value creation by advancing ProTrans in adult patients, w ...
Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on ...
Vietnam Investment Review on MSN
SHPT Deploys Fuel Cells in Hydrogen UAV Project
SHANGHAI, Jan. 20, 2026 /PRNewswire/ -- As a high-tech enterprise in the fuel cell sector, Shanghai Hydrogen Propulsion Technology Co., Ltd. (abbreviated as "SHPT") has upheld its corporate vision of ...
The Company enters 2026 with Multiple Phase 2 Catalysts, AI-enabled drug development strategy, and regulatory optionality as ...
Bloom Energy offers onsite power generation through solid oxide fuel cells that are behind the meter to reduce dependency on ...
Both platforms are backed by over 50 peer-reviewed publications representing decades of development. The addressable markets span multiple areas: Alzheimer's disease ($32.8 billion by 2033), ...
Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results